873063-62-8 Usage
Uses
Used in Organic Synthesis:
(R)-3-Iodo-tetrahydrofuran is used as a chiral building block for the synthesis of various iodinated compounds. Its high reactivity and selectivity make it a valuable tool in organic chemistry, enabling the creation of a wide range of chemical products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (R)-3-Iodo-tetrahydrofuran is utilized as a key reagent in the synthesis of bioactive molecules and pharmaceutical intermediates. Its unique properties contribute to the development of new drugs and drug delivery systems, enhancing the efficacy and bioavailability of pharmaceutical products.
Used in Drug Development:
(R)-3-Iodo-tetrahydrofuran is employed in the development of new drugs, particularly in the creation of innovative drug delivery systems. Its potential use in this area has been investigated, and it has shown promise in improving the therapeutic outcomes of various pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 873063-62-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,6 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 873063-62:
(8*8)+(7*7)+(6*3)+(5*0)+(4*6)+(3*3)+(2*6)+(1*2)=178
178 % 10 = 8
So 873063-62-8 is a valid CAS Registry Number.
873063-62-8Relevant articles and documents
PYRAZOLO[4,3-B]PYRIDINE-7-AMINE INHIBITORS OF ALK5
-
Page/Page column 120-121, (2011/12/04)
The present invention provides ALK5 inhibitors of the formula (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, methods of making the compounds and intermediates thereof; and methods of using the compounds.
3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS
-
Page/Page column 50, (2008/06/13)
The present invention is directed to compounds of Formula I: which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.